![Martin Handfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Handfield
Keine laufenden Positionen mehr
Profil
Martin Handfield is the founder of IviGene Corp., Epicure Corp.
Dr. Handfield is currently President, Chief Executive Officer & Director at neuropacs Corp.
Formerly, Dr. Handfield was Vice President-Research & Development at Oragenics, Inc. from 2012 to 2014, Associate Professor at Center of Molecular Microbiology, and Associate Professor at the University of Florida College of Dentistry.
Dr. Handfield completed undergraduate, graduate, and doctorate degrees at Université Laval.
Aktive Positionen von Martin Handfield
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Martin Handfield
| Unternehmen | Position | Ende |
|---|---|---|
| ORAGENICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.12.2014 |
Epicure Corp.
 Epicure Corp. Internet RetailRetail Trade Operates an as online grocery receipts shop | Gründer | - |
University of Florida College of Dentistry
 University of Florida College of Dentistry Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
IviGene Corp.
 IviGene Corp. Pharmaceuticals: OtherHealth Technology Develops technologies for identifying novel drug targets for treating a broad range of infectious diseases | Gründer | - |
Center of Molecular Microbiology | Corporate Officer/Principal | - |
Ausbildung von Martin Handfield
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
20
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Oragenics, Inc.
 Oragenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics and treatments against infectious disease and oral mucositis | Health Technology |
IviGene Corp.
IviGene Corp. Pharmaceuticals: OtherHealth Technology Develops technologies for identifying novel drug targets for treating a broad range of infectious diseases | Health Technology |
Université Laval
 Université Laval Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center of Molecular Microbiology | |
University of Florida College of Dentistry
University of Florida College of Dentistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epicure Corp.
Epicure Corp. Internet RetailRetail Trade Operates an as online grocery receipts shop | Retail Trade |
